SequelSEC

Aimei Health Technology Co., Ltd. AFJK

Blank Checks · CIK 0001979005 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2025-12-31
Operating income
-$835.76K
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

Valuation, from the filing

Public float$44.55MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$14.07Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / net income42.0×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Blank Checks filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Current ratio0.00x1th

Aimei Health Technology Co., Ltd. (AFJK) reported net income of $1.06M for the fiscal year ended 2025-12-31. This page shows 2 annual periods of income statement, balance sheet and cash flow figures normalized from Aimei Health Technology Co., Ltd.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Blank Checks.

Income

Aimei Health Technology Co., Ltd. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-31
RevenueUnavailableUnavailable
Cost of revenueUnavailableUnavailable
Gross profitUnavailableUnavailable
Operating income-$835.76K-$1.06M
Net income$1.06M$2.55M
Research & developmentUnavailableUnavailable
Weighted-average diluted sharesUnavailableUnavailable
Pretax incomeUnavailableUnavailable
Income tax expense$0$0
Diluted EPSUnavailableUnavailable
Selling, general & administrativeUnavailableUnavailable
General & administrativeUnavailableUnavailable
Selling & marketingUnavailableUnavailable

Balance

Aimei Health Technology Co., Ltd. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-31
Cash & equivalentsUnavailableUnavailable
Total assets$12.10M$73.81M
Current assets$2.93K$30.38K
Total liabilities$4.06M$1.51M
Current liabilities$3.37M$816.99K
Total equity incl. NCI-$4.06M-$1.48M
Temporary (mezzanine) equity$12.10M$73.78M
InventoryUnavailableUnavailable
Accounts receivableUnavailableUnavailable
GoodwillUnavailableUnavailable
Long-term debtUnavailableUnavailable
Accounts payableUnavailableUnavailable

Cash flow

Aimei Health Technology Co., Ltd. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-31
Operating cash flow-$565.10K-$672.29K
Capital expendituresUnavailableUnavailable
Investing cash flow$63.58M-$277.70K
Financing cash flow-$63.04M$397.48K
Net change in cash-$25.28K-$552.51K
Stock-based compensationUnavailableUnavailable
Common dividends paidUnavailableUnavailable
Common share repurchasesUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailable

Derived

Aimei Health Technology Co., Ltd. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-31
Free cash flowUnavailableUnavailable
Gross marginUnavailableUnavailable
Operating marginUnavailableUnavailable
FCF marginUnavailableUnavailable
SBC / revenueUnavailableUnavailable
Current ratio0.00x0.04x
Revenue YoY growthUnavailableUnavailable
Net marginUnavailableUnavailable
R&D / revenueUnavailableUnavailable
CapEx / revenueUnavailableUnavailable
Long-term debt / equityUnavailableUnavailable
Effective tax rateUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open AFJK in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-06-16View SEC filing
10-K · Filed 2026-05-04View SEC filing
10-Q · Filed 2025-11-18View SEC filing
10-K/A · Filed 2025-08-26View SEC filing
10-Q · Filed 2025-08-13View SEC filing

Companies in the same industry

AACI AACO ADAC AEAQ AESP AEXA AIIA ALCYF ALDA ALDF ALFUU ALOV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.